Johnson & Johnson vaccinations resume after investigation
April 26, 2021
Although the vote was not unanimous, with 10 out of 15 committee members voting to lift the pause, Johnson & Johnson vaccinations have resumed. Now, the vaccine will be tagged with a new safety label to indicate the risk of a rare blood clotting syndrome for women under the age of 50. The vaccine’s original recommendation of its authorization for people 18 or older remains the same.